Cutaneous Fibrosis Treatment Market: How Are TGF-β and CTGF-Targeted Biologics Reshaping Scleroderma Skin Management?
Cutaneous fibrosis treatment — the pharmacological, procedural, and physical therapeutic interventions targeting excessive collagen deposition and fibroblast activation in skin-restricted and systemic disorders including localized scleroderma, systemic sclerosis (SSc), keloids, chronic graft-versus-host disease (GVHD), and radiation-induced fibrosis — represents the most underserved...
0 Commentaires 0 Parts 2 Vue 0 Aperçu
BuzzingAbout https://www.buzzingabout.com